Skip to content

Evaluation of the Effect of Corrected Common Carotid Artery Flow Time Combined with Fluid Therapy on Preventing Hypotension After Spinal Anesthesia in Parturients"

Evaluation of the Effect of Corrected Flow Time of the Common Carotid Artery Combined with Fluid Therapy on Preventing Hypotension After Spinal Anesthesia in Parturients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106610
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-07-28
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension after spinal anesthesia,SAIH)

Interventions

Group S (with FTc below the cutoff value):Total infusion volume of 6 mL/kg succinylated gelatin over 30 minutes.
Group G (with FTc >=threshold value):Total infusion volume of 8 mL/kg succinylated gelatin over 30 minutes.

Sponsors

SuZhou Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women scheduled for cesarean section under spinal anesthesia 2. ASA physical status classification I-III 3. Singleton pregnancy 4. Age 18-40 years 5. Gestational age >=37 weeks 6. Body Mass Index (BMI) 20-40 7. Absence of psychiatric disorders.

Exclusion criteria

Exclusion criteria: 1. Refusal to participate or refusal to undergo ultrasound 2. Known allergy to colloids or medications used in the study 3. Concomitant diseases (e.g., diabetes mellitus, hyperthyroidism, epilepsy) 4. Preoperative hypertension with preeclampsia 5. Blood pressure >=160/100 mmHg Common carotid artery stenosis with anatomical variations, atherosclerosis, thrombosis, or history of neck surgery 6. Comorbid cardiovascular/cerebrovascular diseases, hepatic/renal insufficiency, chronic obstructive diseases, arrhythmia, or psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Incidence of hypotension;Total dose of vasoactive drugs administered;

Secondary

MeasureTime frame
Apgar Score;The incidence of nausea and vomiting;

Countries

China

Contacts

Public ContactZhou Yiquan

SuZhou Municipal Hospital

976066594@qq.com+86 177 5895 8573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026